1. Preparation of Compound Salvia miltiorrhiza - Blumea balsamifera Nanoemulsion Gel and Its Effect on Hypertrophic Scars in the Rabbit Ear Model.
- Author
-
Chen T, Wang Z, Gong X, Zhang J, Zhang N, Yang J, Zhu Y, and Zhou Y
- Subjects
- Rabbits, Animals, Drugs, Chinese Herbal chemistry, Drugs, Chinese Herbal pharmacology, Disease Models, Animal, Skin drug effects, Skin pathology, Skin metabolism, Administration, Cutaneous, Particle Size, Male, Nanoparticles chemistry, Medicine, Chinese Traditional methods, Ear pathology, Drug Delivery Systems methods, Cicatrix, Hypertrophic drug therapy, Salvia miltiorrhiza chemistry, Skin Absorption drug effects, Gels, Emulsions chemistry
- Abstract
Hypertrophic scars (HS) still remain an urgent challenge in the medical community. Traditional Chinese medicine (TCM) has unique advantages in the treatment of HS. However, due to the natural barrier of the skin, it is difficult for the natural active components of TCM to more effectively penetrate the skin and exert therapeutic effects. Therefore, the development of an efficient drug delivery system to facilitate enhanced transdermal absorption of TCM becomes imperative for its clinical application. In this study, we designed a compound Salvia miltiorrhiza - Blumea balsamifera nanoemulsion gel (CSB-NEG) and investigated its therapeutic effects on rabbit HS models. The prescription of CSB-NEG was optimized by single-factor, pseudoternary phase diagram, and central composite design experiments. The results showed that the average particle size and PDI of the optimized CSB-NE were 46.0 ± 0.2 nm and 0.222 ± 0.004, respectively, and the encapsulation efficiency of total phenolic acid was 93.37 ± 2.56%. CSB-NEG demonstrated excellent stability and skin permeation in vitro and displayed a significantly enhanced ability to inhibit scar formation compared to the CSB physical mixture in vivo . After 3 weeks of CSB-NEG treatment, the scar appeared to be flat, pink, and flexible. Furthermore, this treatment also resulted in a decrease in the levels of the collagen I/III ratio and TGF-β
1 and Smad2 proteins while simultaneously promoting the growth and remodeling of microvessels. These findings suggest that CSB-NEG has the potential to effectively address the barrier properties of the skin and provide therapeutic benefits for HS, offering a new perspective for the prevention and treatment of HS.- Published
- 2024
- Full Text
- View/download PDF